NCT02181218 2020-11-17Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive LymphomasWashington University School of MedicinePhase 1 Completed24 enrolled